Home4527 • TYO
add
Rohto Pharmaceutical Co Ltd
Previous close
¥3,036.00
Day range
¥3,040.00 - ¥3,095.00
Year range
¥2,666.50 - ¥4,117.00
Market cap
728.14B JPY
Avg Volume
921.56K
P/E ratio
22.82
Dividend yield
0.78%
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 73.29B | 11.14% |
Operating expense | 29.16B | 9.27% |
Net income | 9.56B | 13.24% |
Net profit margin | 13.05 | 1.87% |
Earnings per share | — | — |
EBITDA | 16.25B | 14.55% |
Effective tax rate | 30.80% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 81.88B | 5.46% |
Total assets | 342.16B | 9.73% |
Total liabilities | 96.15B | -2.27% |
Total equity | 246.01B | — |
Shares outstanding | 228.14M | — |
Price to book | 2.89 | — |
Return on assets | 10.56% | — |
Return on capital | 14.17% | — |
Cash Flow
Net change in cash
| (JPY) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 9.56B | 13.24% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Rohto Pharmaceutical Co., Ltd. is a multinational corporation in fast-moving consumer goods and pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan. with revenues steadily increasing from ¥95,619 million in 2006 to ¥120,292 million in 2011. Skin care contributes to 61.3% of the revenues, while Eye Care contributes to 21% of their sales. Wikipedia
CEO
Founded
1899
Headquarters
Website
Employees
7,176
